Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115665) titled 'Helicobacter pylori Infection and Its Effects on Immunotherapy Outcomes in Advanced Gastric Cancer: A Multicenter, Prospective Clinical Research (HOPE-GC)' on Dec. 30, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Gastric cancer
Intervention:
Pylori negative group:No intervention
Recruitment Status: Recruiting
Phase: 0
Date of First Enrollment: 2025-12-30
Target Sample Size: Pylori negative group:200;Pylori positive group:200;
Countries of Recruitment:
China
To know more, visit https://www...